193 related articles for article (PubMed ID: 18788656)
1. Eszopiclone improves overnight polysomnography and continuous positive airway pressure titration: a prospective, randomized, placebo-controlled trial.
Lettieri CJ; Quast TN; Eliasson AH; Andrada T
Sleep; 2008 Sep; 31(9):1310-6. PubMed ID: 18788656
[TBL] [Abstract][Full Text] [Related]
2. Sedative use during continuous positive airway pressure titration improves subsequent compliance: a randomized, double-blind, placebo-controlled trial.
Lettieri CJ; Collen JF; Eliasson AH; Quast TM
Chest; 2009 Nov; 136(5):1263-1268. PubMed ID: 19567493
[TBL] [Abstract][Full Text] [Related]
3. Effects of a short course of eszopiclone on continuous positive airway pressure adherence: a randomized trial.
Lettieri CJ; Shah AA; Holley AB; Kelly WF; Chang AS; Roop SA;
Ann Intern Med; 2009 Nov; 151(10):696-702. PubMed ID: 19920270
[TBL] [Abstract][Full Text] [Related]
4. A pilot study evaluating acute use of eszopiclone in patients with mild to moderate obstructive sleep apnea syndrome.
Rosenberg R; Roach JM; Scharf M; Amato DA
Sleep Med; 2007 Aug; 8(5):464-70. PubMed ID: 17512799
[TBL] [Abstract][Full Text] [Related]
5. A polysomnography study of eszopiclone in elderly patients with insomnia.
McCall WV; Erman M; Krystal AD; Rosenberg R; Scharf M; Zammit GK; Wessel T
Curr Med Res Opin; 2006 Sep; 22(9):1633-42. PubMed ID: 16968566
[TBL] [Abstract][Full Text] [Related]
6. A randomized placebo-controlled polysomnographic study of eszopiclone in Japanese patients with primary insomnia.
Uchimura N; Kamijo A; Kuwahara H; Uchiyama M; Shimizu T; Chiba S; Inoue Y
Sleep Med; 2012 Dec; 13(10):1247-53. PubMed ID: 23063301
[TBL] [Abstract][Full Text] [Related]
7. A polysomnographic placebo-controlled evaluation of the efficacy and safety of eszopiclone relative to placebo and zolpidem in the treatment of primary insomnia.
Erman MK; Zammit G; Rubens R; Schaefer K; Wessel T; Amato D; Caron J; Walsh JK
J Clin Sleep Med; 2008 Jun; 4(3):229-34. PubMed ID: 18595435
[TBL] [Abstract][Full Text] [Related]
8. The Combination of Supplemental Oxygen and a Hypnotic Markedly Improves Obstructive Sleep Apnea in Patients with a Mild to Moderate Upper Airway Collapsibility.
Edwards BA; Sands SA; Owens RL; Eckert DJ; Landry S; White DP; Malhotra A; Wellman A
Sleep; 2016 Nov; 39(11):1973-1983. PubMed ID: 27634790
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind, placebo-controlled trial of eszopiclone for the treatment of insomnia in patients with chronic low back pain.
Goforth HW; Preud'homme XA; Krystal AD
Sleep; 2014 Jun; 37(6):1053-60. PubMed ID: 24882900
[TBL] [Abstract][Full Text] [Related]
10. Does zolpidem enhance the yield of polysomnography?
Lettieri CJ; Eliasson AH; Andrada T; Khramtsov A; Kristo DA
J Clin Sleep Med; 2005 Apr; 1(2):129-31. PubMed ID: 17561625
[TBL] [Abstract][Full Text] [Related]
11. Eszopiclone versus zopiclone in the treatment of insomnia.
Pinto LR; Bittencourt LR; Treptow EC; Braga LR; Tufik S
Clinics (Sao Paulo); 2016 Jan; 71(1):5-9. PubMed ID: 26872077
[TBL] [Abstract][Full Text] [Related]
12. Zolpidem and Eszopiclone Pre-medication for PSG: Effects on Staging, Titration, and Adherence.
Holley AB; Londeree WA; Sheikh KL; Andrada TF; Powell TA; Khramtsov A; Hostler JM
Mil Med; 2018 Jul; 183(7-8):e251-e256. PubMed ID: 29961838
[TBL] [Abstract][Full Text] [Related]
13. Effects of opioid, hypnotic and sedating medications on sleep-disordered breathing in adults with obstructive sleep apnoea.
Mason M; Cates CJ; Smith I
Cochrane Database Syst Rev; 2015 Jul; (7):CD011090. PubMed ID: 26171909
[TBL] [Abstract][Full Text] [Related]
14. Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder.
Pollack M; Kinrys G; Krystal A; McCall WV; Roth T; Schaefer K; Rubens R; Roach J; Huang H; Krishnan R
Arch Gen Psychiatry; 2008 May; 65(5):551-62. PubMed ID: 18458207
[TBL] [Abstract][Full Text] [Related]
15. Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: a randomized, double-blind, placebo-controlled trial.
Pollack MH; Hoge EA; Worthington JJ; Moshier SJ; Wechsler RS; Brandes M; Simon NM
J Clin Psychiatry; 2011 Jul; 72(7):892-7. PubMed ID: 21367352
[TBL] [Abstract][Full Text] [Related]
16. A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia.
Ancoli-Israel S; Krystal AD; McCall WV; Schaefer K; Wilson A; Claus R; Rubens R; Roth T
Sleep; 2010 Feb; 33(2):225-34. PubMed ID: 20175406
[TBL] [Abstract][Full Text] [Related]
17. Eszopiclone for insomnia associated with attention-deficit/hyperactivity disorder.
Sangal RB; Blumer JL; Lankford DA; Grinnell TA; Huang H
Pediatrics; 2014 Oct; 134(4):e1095-103. PubMed ID: 25266438
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and initial management of obstructive sleep apnea without polysomnography: a randomized validation study.
Mulgrew AT; Fox N; Ayas NT; Ryan CF
Ann Intern Med; 2007 Feb; 146(3):157-66. PubMed ID: 17283346
[TBL] [Abstract][Full Text] [Related]
19. Impact of zaleplon on continuous positive airway pressure therapy compliance.
Park JG; Olson EJ; Morgenthaler TI
J Clin Sleep Med; 2013 May; 9(5):439-44. PubMed ID: 23674934
[TBL] [Abstract][Full Text] [Related]
20. Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations.
Walsh JK; Krystal AD; Amato DA; Rubens R; Caron J; Wessel TC; Schaefer K; Roach J; Wallenstein G; Roth T
Sleep; 2007 Aug; 30(8):959-68. PubMed ID: 17702264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
